PT804562E - Factor 2 de crescimento de tecido conjuntivo - Google Patents

Factor 2 de crescimento de tecido conjuntivo

Info

Publication number
PT804562E
PT804562E PT94925090T PT94925090T PT804562E PT 804562 E PT804562 E PT 804562E PT 94925090 T PT94925090 T PT 94925090T PT 94925090 T PT94925090 T PT 94925090T PT 804562 E PT804562 E PT 804562E
Authority
PT
Portugal
Prior art keywords
polypeptide
conjunctive tissue
tissue growing
growing factor
enhancing
Prior art date
Application number
PT94925090T
Other languages
English (en)
Inventor
Mark D Adams
Haodong Li
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of PT804562E publication Critical patent/PT804562E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT94925090T 1994-07-12 1994-07-12 Factor 2 de crescimento de tecido conjuntivo PT804562E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/007736 WO1996001896A1 (en) 1994-07-12 1994-07-12 Connective tissue growth factor-2

Publications (1)

Publication Number Publication Date
PT804562E true PT804562E (pt) 2003-02-28

Family

ID=22242737

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94925090T PT804562E (pt) 1994-07-12 1994-07-12 Factor 2 de crescimento de tecido conjuntivo

Country Status (10)

Country Link
US (5) US5945300A (pt)
EP (2) EP1217067A2 (pt)
JP (1) JPH10502534A (pt)
AT (1) ATE225850T1 (pt)
AU (1) AU689492B2 (pt)
DE (1) DE69431534T2 (pt)
DK (1) DK0804562T3 (pt)
NZ (1) NZ271488A (pt)
PT (1) PT804562E (pt)
WO (1) WO1996001896A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1217067A2 (en) * 1994-07-12 2002-06-26 Human Genome Sciences, Inc. Connective tissue growth factor-2
US7521540B2 (en) 1996-03-15 2009-04-21 Munin Corporation CYR61 compositions and methods
AU2004202578B2 (en) * 1996-03-15 2007-09-13 Munin Corporation Extracellular matrix signalling molecules
US6413735B1 (en) * 1996-03-15 2002-07-02 Munin Corporation Method of screening for a modulator of angiogenesis
US20090081228A1 (en) * 1996-03-15 2009-03-26 Munin Corporation Cyr61 compositions and methods
US6790606B1 (en) 1996-03-15 2004-09-14 Munin Corporation Extracellular matrix signaling molecules
US20040132987A1 (en) 1996-11-08 2004-07-08 Human Genome Sciences, Inc. Connective tissue growth factor-3
CA2286934A1 (en) * 1997-04-16 1998-10-22 Millennium Pharmaceuticals, Inc. Novel polypeptides within the growth factor superfamily
DE19719652A1 (de) * 1997-05-09 1998-12-03 Merckle Gmbh Tissue-Faktor zur Förderung von Wundheilung
WO1999007850A1 (en) * 1997-08-06 1999-02-18 Millennium Biotherapeutics, Inc. Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides
US5876730A (en) 1997-08-07 1999-03-02 Childrens Hospital Research Foundation Heparin-binding growth factor (HBGF) polypeptides
WO1999042583A1 (en) * 1998-02-20 1999-08-26 Zymogenetics, Inc. Connective tissue growth factor homologs
US6378527B1 (en) * 1998-04-08 2002-04-30 Chondros, Inc. Cell-culture and polymer constructs
US7115390B1 (en) * 1998-12-14 2006-10-03 Fibrogen, Inc. Connective tissue growth factor fragments and methods and uses thereof
CN1170849C (zh) * 1998-12-14 2004-10-13 迈阿密大学 结缔组织生长因子片段及其方法和用途
EP1892250A3 (en) * 2000-01-31 2008-09-17 Munin Corporation CYR61 compositions and methods
US20060052328A1 (en) * 2000-07-11 2006-03-09 Human Genome Sciences, Inc. Connective tissue growth factor-2
WO2005033136A1 (en) * 2003-09-29 2005-04-14 Children's Hospital, Inc. Unique integrin binding site in connective tissue growth factor (ctgf)
TW201102086A (en) 2009-06-04 2011-01-16 Hoffmann La Roche Antibodies against human CCN1 and uses thereof
WO2011107590A1 (en) * 2010-03-04 2011-09-09 Wolfgang Poller Cnn1 (cyr61) for prevention and therapy of inflammatory disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE88899T1 (de) 1986-11-14 1993-05-15 Inst Molecular Biology Inc Wundheilung und knochenregeneration.
DK131988A (da) 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
US5648461A (en) * 1990-02-22 1997-07-15 W.R. Grace & Co.-Conn Synthetic analogs of thrombospondin and therapeutic use thereof
JPH05255397A (ja) * 1991-01-18 1993-10-05 Bristol Myers Squibb Co TGF−β誘導遺伝子系統群
US5408040A (en) * 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
US5837258A (en) 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
WO1994003599A1 (fr) 1992-08-04 1994-02-17 Sagami Chemical Research Center ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
EP1217067A2 (en) * 1994-07-12 2002-06-26 Human Genome Sciences, Inc. Connective tissue growth factor-2
US7026299B2 (en) * 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
US5792453A (en) 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
US6413735B1 (en) 1996-03-15 2002-07-02 Munin Corporation Method of screening for a modulator of angiogenesis
US5944710A (en) 1996-06-24 1999-08-31 Genetronics, Inc. Electroporation-mediated intravascular delivery
CN1170849C (zh) 1998-12-14 2004-10-13 迈阿密大学 结缔组织生长因子片段及其方法和用途
US20060052328A1 (en) * 2000-07-11 2006-03-09 Human Genome Sciences, Inc. Connective tissue growth factor-2

Also Published As

Publication number Publication date
US20070154908A1 (en) 2007-07-05
NZ271488A (en) 1998-01-26
US6534630B1 (en) 2003-03-18
EP0804562A1 (en) 1997-11-05
US5945300A (en) 1999-08-31
JPH10502534A (ja) 1998-03-10
EP0804562B1 (en) 2002-10-09
DE69431534D1 (de) 2002-11-14
WO1996001896A1 (en) 1996-01-25
EP1217067A2 (en) 2002-06-26
AU689492B2 (en) 1998-04-02
US20030078391A1 (en) 2003-04-24
US20100041136A1 (en) 2010-02-18
DE69431534T2 (de) 2003-06-26
EP0804562A4 (en) 1998-08-05
DK0804562T3 (da) 2003-02-10
ATE225850T1 (de) 2002-10-15
AU7513194A (en) 1996-02-09

Similar Documents

Publication Publication Date Title
PT804562E (pt) Factor 2 de crescimento de tecido conjuntivo
DK0759067T3 (da) Transformerende vækstfaktor alfa-H1
ATE298800T1 (de) Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
DE10299044I1 (de) n-Terminal chemisch modifizierte Protein-Zusammensetzungen und Methoden
ATE265529T1 (de) Bmp-10 zusammensetzungen
DK0429570T3 (da) Osteoinducerende præparater
EP0751992A4 (en) VASCULAR ENDOTHELIAL GROWTH FACTOR 2
DK0698094T3 (da) BMP-11-sammensætninger
ATE259243T1 (de) Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse
ATE238417T1 (de) Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
ATE295734T1 (de) Verwendung von fibroblasten-wachstumsfaktor analogen zur stimulation des knochenwachstums
DE69528058D1 (de) Bmp-9 zusammensetzungen
ATE510552T1 (de) Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors
ATE184917T1 (de) Rekombinante methode und wirt zur herstellung von xylitol
ATE167232T1 (de) Protein mit knochenbildungs-eigenschaften und verfahren zu seiner herstellung
ATE258933T1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
DE60025830D1 (de) Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung
WO2002004480A3 (en) Connective tissue growth factor-2
DE69634994D1 (de) Bindegewebe-wachstumsfaktor 3.
EP0826041A4 (en) Transforming growth factor alpha hii
ES2180585T3 (es) Factor de crecimiento de tejido conjuntivo-2.